期刊
NATURE REVIEWS DRUG DISCOVERY
卷 13, 期 7, 页码 533-548出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrd4334
关键词
-
资金
- US National Institutes of Health (NIH) (NIDCR) [R01DE17794, R01DE22743]
- National Institute of Neurological Disorders and Stroke (NINDS) [R21NS082985, R01NS67686]
- National Natural Science Foundation of China grant (NSFC) [31171062, 31371121]
Current analgesics predominately modulate pain transduction and transmission in neurons and have limited success in controlling disease progression. Accumulating evidence suggests that neuroinflammation, which is characterized by infiltration of immune cells, activation of glial cells and production of inflammatory mediators in the peripheral and central nervous system, has an important role in the induction and maintenance of chronic pain. This Review focuses on emerging targets - such as chemokines, proteases and the WNT pathway - that promote spinal cord neuroinflammation and chronic pain. It also highlights the anti-inflammatory and pro-resolution lipid mediators that act on immune cells, glial cells and neurons to resolve neuroinflammation, synaptic plasticity and pain. Targeting excessive neuroinflammation could offer new therapeutic opportunities for chronic pain and related neurological and psychiatric disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据